Schonfeld Strategic Advisors LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 114 filers reported holding RELMADA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$327,930
+24.8%
109,310
+45.2%
0.00%
+50.0%
Q4 2022$262,797
-95.3%
75,300
-50.0%
0.00%
-95.7%
Q3 2022$5,572,000
+351.2%
150,500
+174.6%
0.05%
+327.3%
Q4 2021$1,235,000
-58.3%
54,800
-51.5%
0.01%
-64.5%
Q3 2021$2,961,000
+60.2%
112,938
+95.5%
0.03%
+55.0%
Q2 2021$1,848,000
-3.6%
57,761
+6.0%
0.02%
-13.0%
Q1 2021$1,918,00054,5010.02%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
VR Adviser, LLC 668,440$25,147,0004.92%
TANG CAPITAL MANAGEMENT LLC 500,000$18,810,0003.40%
ACUTA CAPITAL PARTNERS, LLC 277,000$10,421,0002.83%
PARSONS CAPITAL MANAGEMENT INC/RI 455,137$17,122,0001.67%
RTW INVESTMENTS, LP 1,511,337$56,857,0001.37%
Avoro Capital Advisors LLC 1,500,000$56,430,0000.80%
Pegasus Asset Management, Inc. 26,958$1,014,0000.64%
RA Capital Management 781,290$29,392,0000.54%
TIEDEMANN ADVISORS, LLC 269,839$10,151,0000.49%
Boxer Capital, LLC 300,000$11,286,0000.39%
View complete list of RELMADA THERAPEUTICS INC shareholders